Susan Purdy

768 total citations
9 papers, 578 citations indexed

About

Susan Purdy is a scholar working on Hepatology, Epidemiology and Behavioral Neuroscience. According to data from OpenAlex, Susan Purdy has authored 9 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 4 papers in Epidemiology and 2 papers in Behavioral Neuroscience. Recurrent topics in Susan Purdy's work include Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Susan Purdy is often cited by papers focused on Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Susan Purdy collaborates with scholars based in United States, Netherlands and Germany. Susan Purdy's co-authors include Lindsay McNair, Christine J. Weegink, Stefan Zeuzem, Peter L. M. Jansen, Nicole Forestier, Hendrik W. Reesink, John Alam, André van Vliet, Robert S. Kauffman and Jeroen van de Wetering de Rooij and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

Susan Purdy

9 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan Purdy United States	8	518	422	174	64	54	9	578
Giancarlo Serra Italy	6	465 0.9×	430 1.0×	43 0.2×	33 0.5×	26 0.5×	17	554
Isabelle Lonjon‐Domanec France	14	541 1.0×	522 1.2×	79 0.5×	48 0.8×	35 0.6×	37	596
S. Hadziyannis Greece	18	981 1.9×	1.0k 2.4×	87 0.5×	32 0.5×	53 1.0×	55	1.2k
Retno Handajani Indonesia	12	319 0.6×	336 0.8×	43 0.2×	11 0.2×	21 0.4×	48	438
Mathieu Lefèvre France	6	194 0.4×	177 0.4×	26 0.1×	43 0.7×	71 1.3×	7	299
U. Karey Germany	5	323 0.6×	259 0.6×	160 0.9×	32 0.5×	26 0.5×	6	339
Satomi Iwasaki Japan	13	458 0.9×	436 1.0×	91 0.5×	69 1.1×	29 0.5×	22	519
Markus Zettler Germany	4	256 0.5×	203 0.5×	142 0.8×	29 0.5×	25 0.5×	8	285
Stefano De Virgilis Italy	5	318 0.6×	309 0.7×	26 0.1×	33 0.5×	30 0.6×	8	398
Chiara Nardi Italy	10	190 0.4×	141 0.3×	78 0.4×	9 0.1×	83 1.5×	20	365

Countries citing papers authored by Susan Purdy

Since Specialization

Citations

This map shows the geographic impact of Susan Purdy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Purdy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Purdy more than expected).

Fields of papers citing papers by Susan Purdy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Purdy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Purdy. The network helps show where Susan Purdy may publish in the future.

Co-authorship network of co-authors of Susan Purdy

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Purdy. A scholar is included among the top collaborators of Susan Purdy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Purdy. Susan Purdy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Gelderblom, Huub C., Stefan Zeuzem, Christine J. Weegink, et al.. (2008). Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS3•4A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2a. Scandinavian Journal of Gastroenterology. 43(9). 1122–1127. 10 indexed citations

Marcellin, Patrick, Yves Horsmans, Frederik Nevens, et al.. (2007). Phase 2 study of the combination of merimepodib with peginterferon-α2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C. Journal of Hepatology. 47(4). 476–483. 20 indexed citations

Gelderblom, Huub C., Stefan Zeuzem, Nicole Forestier, et al.. (2007). [592] NEOPTERIN AND ALT AS MARKERS OF INFLAMMATION IN CHRONIC HEPATITIS C PATIENTS DURING ADMINISTRATION OF THE HCV NS3-4A PROTEASE INHIBITOR TELAPREVIR (VX-950) IN COMBINATION WITH PEGINTERFERON ALFA 2a. Journal of Hepatology. 46. S224–S225. 2 indexed citations

Forestier, Nicole, Hendrik W. Reesink, Christine J. Weegink, et al.. (2007). Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C. Hepatology. 46(3). 640–648. 189 indexed citations

Reesink, Hendrik W., Stefan Zeuzem, Christine J. Weegink, et al.. (2006). Rapid Decline of Viral RNA in Hepatitis C Patients Treated With VX-950: A Phase Ib, Placebo-Controlled, Randomized Study. Gastroenterology. 131(4). 997–1002. 291 indexed citations

Reesink, H.W., Christine J. Weegink, Stefan Zeuzem, et al.. (2006). 737 Initial results of a 14-day study of the hepatitis C virus inhibitor protease VX-950, in combination with peginterferon-alpha-2a. Journal of Hepatology. 44. S272–S272. 20 indexed citations

Kieffer, Tara L., C. Sarrazin, Doug J. Bartels, et al.. (2006). 12 Wild-type HCV NS3 protease re-emerges during follow-up after 14 days of dosing with VX-950 in patients with genotype 1 HCV. Journal of Hepatology. 44. S7–S7. 13 indexed citations

Whitehouse, B. J., Susan Purdy, & D.R.E. Abayasekara. (1993). Inhibition of corticosteroid production by sodium pentobarbitone in rat adrenocortical preparations. Journal of Endocrinology. 136(1). 75–83. 7 indexed citations

Purdy, Susan, B. J. Whitehouse, & D.R.E. Abayasekara. (1991). Stimulation of steroidogenesis by forskolin in rat adrenal zona glomerulosa cell preparations. Journal of Endocrinology. 129(3). 391–397. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact